JMI Syringes & Medical Devices Limited announcements
208 Dhaka Stock Exchange announcements for JMI Syringes & Medical Devices Limited (JMISMDL) since 2013: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (17).
- Credit Rating Result
Alpha Credit Rating PLC. (Alpha Rating) has assigned surveillance rating of the Company as "AA" in the long term and "ST-1" in the short term along with Stable outlook based on audited financial statements as on June 30, 2025 and relevant qualitative information till December 21, 2025.
- Emphasis of Matter
The auditor of the company has given the Emphasis of Matter paragraph in the auditor's report of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JMISMDL_2025.pdf
- Resumption after Record Date
Trading of the shares of the company will resume on 18.11.2025.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. (0.50) for July-September 2025 as against Tk. 0.73 for July-September 2024. NOCFPS was Tk. (2.17) for July-September 2025 as against Tk. 1.05 for July-September 2024. NAV per share was Tk. 86.73 as on September 30, 2025 and Tk. 87.23 as on June 30, 2025. Reasons for deviation: During the reported period Net profit after Tax and EPS are decreased in comparison with previous period due to decrease of sales and increases of all type of expenses. (cont.) (Cont. News of JMISMDL): NOCFPS has been negative significantly due to net losses, increased material purchases and increased closing inventory in the current period compared to previous period. NAVPS decreased slightly due to the net loss after tax in the business during the period compared to previous period. (end)
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 17.11.2025.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 13.11.2025 to 16.11.2025 and trading of the shares will remain suspended on record date i.e., 17.11.2025.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2025 at 2:35 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
- Dividend Declaration
The Board of Directors has recommended 10% Cash Dividend for the year ended June 30, 2025. Date of AGM: 23.12.2025; Time: 11:30 AM; Venue/Mode of AGM: Virtually by using Digital Platform. Link: https://jmismdl.bdvirtualagm.com. Record Date: 17.11.2025. The Company has also reported EPS of Tk. 1.49, NAV per share of Tk. 87.23 and NOCFPS of Tk. 3.57 for the year ended June 30, 2025 as against Tk. 1.29, Tk. 86.66 and Tk. 4.06 respectively for the year ended June 30, 2024.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (28.10.2025) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2025 at 2:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.02) for January-March 2025 as against Tk. 0.36 for January-March 2024; EPS was Tk. 1.68 for July 2024-March 2025 as against Tk. 0.50 for July 2023-March 2024. NOCFPS was Tk. 2.67 for July 2024-March 2025 as against Tk. 3.38 for July 2023-March 2024. NAV per share was Tk. 87.44 as on March 31, 2025 and Tk. 86.66 as on June 30, 2024. Significant Deviation: EPS: During the reported period Sales, Net profit after Tax and Earning per Share (EPS) (cont.) (cont. news of JMISMDL): are increased in comparison with previous period due to increase of sales & increase of sales price of the products and also trying to reducing expenses. NOCFPS: During the current period, payments to suppliers and salaries, bonuses and allowances to employees on the occasion of the holy Eid ul Fiter have been made. Due to this, operating cash flow has been slightly lower than the previous period. (end)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2025 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
- Regarding revaluation of Property, Plant and Equipment of the company
The company has informed that the Board of Directors has approved the Revaluation of Property, Plant and Equipment (Land & Factory Buildings) based on December 31, 2024. To view the details, please visit: https://www.dsebd.org/Annexure/2024/JMISYRINGES_2024.pdf
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.98 for October-December 2024 as against Tk. 0.07 for October-December 2023; EPS was Tk. 1.71 for July-December 2024 as against Tk. 0.15 for July-December 2023. NOCFPS was Tk. 2.93 for July-December 2024 as against Tk. 2.44 for July-December 2023. NAV per share was Tk. 87.37 as on December 31, 2024 and Tk. 86.66 as on June 30, 2024. (cont.1) (cont. news of JMISMDL): NOCFPS: At the end of this period collection was increases compared to the sales of our products so that the Net Operating Cash Flow per Share (NOCFPS) was slightly increased compared to the previous period. (end) (cont. news of JMISMDL): Significant Deviation: EPS: During the reported period Sales, Net profit after Tax and Earning per Share (EPS) are increased in comparison with previous period due to increase of sales & increase of sales price of the products and also trying to reducing expenses. NAVPS: At the end of the current period, the net asset value per share (NAV) has increased slightly compared to the previous period due to increase of Net Profit after Taxes. (cont.2)
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2025 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
- Credit Rating Result
Alpha Credit Rating Limited (Alpha Rating) has assigned the Surveillance rating of the Company as "AA-" in the long term and "ST-1" in the short term along with Stable outlook based on the audited financial statement up to June 30, 2024 and relevant qualitative information till December 30, 2024.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.